“…Additionally, previous studies have demonstrated that high levels of NEFA are involved in triggering hepatic FGF-21 production, and conditions with high insulin resistance, such as obesity, are associated with FGF-21-resistant states, and thus showing increased circulating levels of endogenous FGF-21 [ 10 , 48 ]. NEFA changes during pregnancy reached the highest levels in the third trimester and were positively associated with maternal insulin resistance [ 39 , 49 , 50 , 51 ]. Another effect of high free fatty acid (FFA) levels is to increase levels of ROS in endothelial cells and smooth muscle cells.…”